ID24054A - Turunan turunan benzimidazol - Google Patents

Turunan turunan benzimidazol

Info

Publication number
ID24054A
ID24054A IDW20000038A ID20000038A ID24054A ID 24054 A ID24054 A ID 24054A ID W20000038 A IDW20000038 A ID W20000038A ID 20000038 A ID20000038 A ID 20000038A ID 24054 A ID24054 A ID 24054A
Authority
ID
Indonesia
Prior art keywords
benzimidazol
benzimidazol down
Prior art date
Application number
IDW20000038A
Other languages
English (en)
Indonesian (id)
Inventor
John Charlas Drach
Leroy B Townsend
Frank Leslie Boyd Jr
Stanley Dawes Chamberlain
Susan Mary Daluge
David Norman Daeton
Marc W Andersen
George Andrew Freeman
Original Assignee
Glaxo Group Ltd Glaxo
Univ Michigan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9711982.0A external-priority patent/GB9711982D0/en
Priority claimed from GBGB9714552.8A external-priority patent/GB9714552D0/en
Application filed by Glaxo Group Ltd Glaxo, Univ Michigan filed Critical Glaxo Group Ltd Glaxo
Publication of ID24054A publication Critical patent/ID24054A/id

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/30—Nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/052—Imidazole radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Saccharide Compounds (AREA)
IDW20000038A 1997-06-10 1998-06-08 Turunan turunan benzimidazol ID24054A (id)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9711982.0A GB9711982D0 (en) 1997-06-10 1997-06-10 Benzimidazole derivatives
GBGB9714552.8A GB9714552D0 (en) 1997-07-11 1997-07-11 Benzimidazole derivatives

Publications (1)

Publication Number Publication Date
ID24054A true ID24054A (id) 2000-07-06

Family

ID=26311687

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW20000038A ID24054A (id) 1997-06-10 1998-06-08 Turunan turunan benzimidazol

Country Status (34)

Country Link
US (1) US6455507B1 (de)
EP (1) EP0994890B1 (de)
JP (1) JP4548866B2 (de)
KR (1) KR20010020465A (de)
CN (1) CN1265665A (de)
AP (1) AP1262A (de)
AR (1) AR012964A1 (de)
AT (1) ATE246700T1 (de)
AU (1) AU740792C (de)
BR (1) BR9810745A (de)
CA (1) CA2293470C (de)
CO (1) CO4970737A1 (de)
DE (1) DE69816992T2 (de)
DK (1) DK0994890T3 (de)
EA (1) EA002305B1 (de)
EE (1) EE9900564A (de)
ES (1) ES2205527T3 (de)
HR (1) HRP980303B1 (de)
HU (1) HUP0002224A3 (de)
ID (1) ID24054A (de)
IL (1) IL133285A0 (de)
IS (1) IS5285A (de)
MA (1) MA26504A1 (de)
MY (1) MY132872A (de)
NO (1) NO314847B1 (de)
NZ (1) NZ501415A (de)
OA (1) OA11230A (de)
PE (1) PE84099A1 (de)
PL (1) PL337773A1 (de)
PT (1) PT994890E (de)
SK (1) SK171499A3 (de)
TR (1) TR199903053T2 (de)
TW (1) TW565566B (de)
WO (1) WO1998056761A2 (de)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5840743A (en) 1996-01-23 1998-11-24 The Regents Of The University Of Michigan Modified benzimidazole nucleosides as antiviral agents
AU744176B2 (en) 1997-07-30 2002-02-14 Glaxo Group Limited Lyxofuranosyl benzimidazoles as antiviral agents
DE19741715A1 (de) * 1997-09-22 1999-03-25 Hoechst Ag Pentopyranosyl-Nucleosid, seine Herstellung und Verwendung
GB0008939D0 (en) * 2000-04-11 2000-05-31 Glaxo Group Ltd Process for preparing substituted benzimidazole compounds
BR0208010A (pt) 2001-03-12 2004-12-21 Avanir Pharmaceuticals Composto de benzimidazol para modulação de ige e inibição de proliferação celular
TWI276631B (en) 2002-09-12 2007-03-21 Avanir Pharmaceuticals Phenyl-aza-benzimidazole compounds for modulating IgE and inhibiting cellular proliferation
AU2003270426A1 (en) 2002-09-12 2004-04-30 Avanir Pharmaceuticals PHENYL-INDOLE COMPOUNDS FOR MODULATING IgE AND INHIBITING CELLULAR PROLIFERATION
AU2004261663A1 (en) * 2003-08-01 2005-02-10 Janssen Pharmaceutica N.V. Substituted benzimidazole-, benztriazole-, and benzimidazolone-O-glucosides
WO2005049582A1 (en) * 2003-11-14 2005-06-02 Auspex Pharmaceuticals, Inc. Method of preparation of novel nucleoside analogs and uses
AU2006216780B8 (en) * 2005-02-22 2010-04-22 The Regents Of The University Of Michigan Small molecule inhibitors of MDM2 and uses thereof
DE102005019549A1 (de) * 2005-04-25 2006-12-14 Beiersdorf Ag Kosmetische oder dermatologische Zubereitungen mit einem Gehalt an Diaminobenzimidazol
US7989422B2 (en) * 2005-12-22 2011-08-02 Alchemia Limited Antibacterial agents
US8927528B2 (en) 2006-01-19 2015-01-06 The Regents Of The University Of Michigan Composition for treating hearing loss
US9919008B2 (en) 2006-01-19 2018-03-20 The Regents Of The University Of Michigan Method for treating age-related hearing loss (ARHL)
US9770433B2 (en) 2006-01-19 2017-09-26 The Regents Of The University Of Michigan Composition and method for treating tinnitus
USRE46372E1 (en) 2006-01-19 2017-04-25 The Regents Of The Univerity Of Michigan Method for treating hearing loss
US7951845B2 (en) 2006-01-19 2011-05-31 The Regents Of The University Of Michigan Composition and method of treating hearing loss
US8338397B2 (en) 2006-01-19 2012-12-25 The Regents Of The University Of Michigan Composition and method of treating side effects from antibiotic treatment
US9889156B2 (en) 2006-01-19 2018-02-13 The Regents Of The University Of Michigan Method for treating noise-induced hearing loss (NIHL)
US10238599B2 (en) 2006-01-19 2019-03-26 The Regents Of The University Of Michigan Composition and method for treating congenital cytomegalovirus induced hearing loss
EP2188298B1 (de) 2007-08-15 2013-09-18 Isis Pharmaceuticals, Inc. Tetrahydropyrannukleinsäureanaloga
US8987468B2 (en) * 2008-02-04 2015-03-24 The Translational Genomics Research Institute Compounds, pharmaceutical compositions and methods of use of hydroxamic acid derivatives
EP2265627A2 (de) 2008-02-07 2010-12-29 Isis Pharmaceuticals, Inc. Bicyclische cyclohexitolnukleinsäureanaloga
CN102361857B (zh) 2008-09-26 2015-09-16 默沙东公司 可用作抗糖尿病剂的环状苯并咪唑衍生物
US8410284B2 (en) 2008-10-22 2013-04-02 Merck Sharp & Dohme Corp Cyclic benzimidazole derivatives useful as anti-diabetic agents
JP2012507530A (ja) 2008-10-29 2012-03-29 メルク・シャープ・エンド・ドーム・コーポレイション 有用な抗糖尿病剤である新規な環状ベンズイミダゾール誘導体
WO2010051206A1 (en) 2008-10-31 2010-05-06 Merck Sharp & Dohme Corp. Novel cyclic benzimidazole derivatives useful anti-diabetic agents
US8536320B2 (en) 2009-02-06 2013-09-17 Isis Pharmaceuticals, Inc. Tetrahydropyran nucleic acid analogs
EP2393825A2 (de) 2009-02-06 2011-12-14 Isis Pharmaceuticals, Inc. Oligomere verbindungen und verfahren
JP2013520502A (ja) 2010-02-25 2013-06-06 メルク・シャープ・エンド・ドーム・コーポレイション 有用な抗糖尿病薬である新規な環状ベンズイミダゾール誘導体
WO2011139702A2 (en) 2010-04-28 2011-11-10 Isis Pharmaceuticals, Inc. Modified nucleosides and oligomeric compounds prepared therefrom
US8546344B2 (en) 2010-10-28 2013-10-01 Viropharma Incorporated Crystalline phases of 5,6-dichloro-2-(isopropylamino)-1-β-L-ribofuranosyl)-1H-benzimidazole
WO2014134493A1 (en) * 2013-03-01 2014-09-04 Los Alamos National Security, Llc Broad spectrum antibiotic compounds and use thereof
US9926556B2 (en) 2014-04-28 2018-03-27 Ionis Pharmaceuticals, Inc. Linkage modified oligomeric compounds
WO2016089845A1 (en) * 2014-12-01 2016-06-09 Virginia Commonwealth University A convergent approach to the total synthesis of telmisartan via a suzuki cross-coupling reaction
RU2629670C2 (ru) * 2016-08-04 2017-08-31 Федеральное государственное бюджетное учреждение науки институт биоорганической химии им. академиков М.М. Шемякина и Ю.А. Овчинникова Российской академии наук (ИБХ РАН) 2-Амино-5,6-дифтор-1-(бета-D-рибофуранозил)-бензимидазол, способ получения и противовирусная активность его в отношении вируса герпеса простого 1-го типа
EP3907230B1 (de) * 2020-03-30 2024-08-28 Biometrix Technology Inc. Neue benzimidazolderivate, verfahren zu ihrer herstellung und ihre verwendung als antikrebsmittel
KR102583547B1 (ko) 2020-03-30 2023-10-06 (주)바이오메트릭스 테크놀로지 신규한 벤지미다졸 유도체, 이의 제조방법 및 이의 항암제 용도
KR102449266B1 (ko) 2020-06-23 2022-09-30 (주)바이오메트릭스 테크놀로지 항암 활성 그리고 항바이러스 활성을 갖는 신규한 벤지미다졸-탄수화물 결합체 화합물(Benzimidazole carbohydrate conjugate compound) 및 이의 제조 방법
KR102342313B1 (ko) 2021-08-27 2021-12-24 (주)바이오메트릭스 테크놀로지 벤지미다졸-탄수화물 결합체 화합물을 포함하는 미셀, 이의 제조방법, 이의 항암제 또는 항바이러스제로서의 용도
CN119119151A (zh) * 2024-09-04 2024-12-13 斯坦德药典标准物质研发(湖北)有限公司 一种马立巴韦的制备方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1491244A (fr) 1966-03-09 1967-08-11 Nouveaux benzimidazoles solubles
FR1476350A (fr) 1966-04-18 1967-04-07 Yale & Towne G M B H Ferme-porte automatique à frein
US3655901A (en) 1970-07-30 1972-04-11 Merck & Co Inc Method of inhibiting the formation of phenylethanalamine-n-methyl transferase with 2-aminobenzimidazoles
DE2130030A1 (de) 1971-06-18 1972-12-21 Bayer Ag Fungizide und bakterizide Mittel
ES8101067A1 (es) 1978-08-25 1980-12-01 Thomae Gmbh Dr K Procedimiento para la preparacion de nuevos bencimidazoles sustituidos en posicion 5 o 6 con un anillo de piridazinona
DK405988A (da) 1987-07-29 1989-01-30 Hoffmann La Roche Benzimidazolderivater
IT1226100B (it) 1988-07-07 1990-12-10 Dompe Farmaceutici Spa Derivati benzimidazolici farmacologicamente attivi.
US5248672A (en) 1990-11-01 1993-09-28 The Regents Of The University Of Michigan Polysubstituted benzimidazole nucleosides as antiviral agents
ZA923641B (en) 1991-05-21 1993-02-24 Iaf Biochem Int Processes for the diastereoselective synthesis of nucleosides
EP0521463A3 (en) 1991-07-04 1993-04-14 Hoechst Aktiengesellschaft Substituted cyclic cycloalkyltriols, process, intermediates for their preparation and their use as antiviral and antiparasitic agents
GB9205071D0 (en) 1992-03-09 1992-04-22 Wellcome Found Therapeutic nucleosides
WO1994008456A1 (en) 1992-10-21 1994-04-28 The Regents Of The University Of Michigan Polysubstituted benzimidazoles as antiviral agents
US5399580A (en) 1993-03-08 1995-03-21 Burroughs Wellcome Co. Therapeutic nucleosides-uses
GB9413724D0 (en) * 1994-07-07 1994-08-24 Wellcome Found Therapeutic nucleosides

Also Published As

Publication number Publication date
EE9900564A (et) 2000-06-15
TW565566B (en) 2003-12-11
EA199901031A1 (ru) 2000-06-26
AP9901707A0 (en) 1999-12-31
JP2002504105A (ja) 2002-02-05
IL133285A0 (en) 2001-04-30
HUP0002224A1 (hu) 2001-04-28
MY132872A (en) 2007-10-31
HRP980303B1 (en) 2002-08-31
CN1265665A (zh) 2000-09-06
CO4970737A1 (es) 2000-11-07
MA26504A1 (fr) 2004-12-20
DE69816992T2 (de) 2004-07-22
NZ501415A (en) 2001-10-26
EP0994890A2 (de) 2000-04-26
WO1998056761A3 (en) 1999-04-15
HUP0002224A3 (en) 2003-05-28
DE69816992D1 (en) 2003-09-11
BR9810745A (pt) 2001-03-13
CA2293470A1 (en) 1998-12-17
PL337773A1 (en) 2000-09-11
ES2205527T3 (es) 2004-05-01
US20020094963A1 (en) 2002-07-18
US6455507B1 (en) 2002-09-24
HK1024921A1 (en) 2000-10-27
WO1998056761A2 (en) 1998-12-17
NO996086D0 (no) 1999-12-09
SK171499A3 (en) 2000-08-14
NO996086L (no) 2000-02-09
ATE246700T1 (de) 2003-08-15
AU740792C (en) 2003-01-23
AU740792B2 (en) 2001-11-15
KR20010020465A (ko) 2001-03-15
AU8536098A (en) 1998-12-30
CA2293470C (en) 2008-05-13
EA002305B1 (ru) 2002-02-28
DK0994890T3 (da) 2003-12-01
IS5285A (is) 1999-12-06
PE84099A1 (es) 1999-09-24
HRP980303A2 (en) 1999-04-30
OA11230A (en) 2003-07-09
TR199903053T2 (xx) 2000-11-21
JP4548866B2 (ja) 2010-09-22
PT994890E (pt) 2003-11-28
NO314847B1 (no) 2003-06-02
AR012964A1 (es) 2000-11-22
EP0994890B1 (de) 2003-08-06
AP1262A (en) 2004-03-16

Similar Documents

Publication Publication Date Title
DK0994890T3 (da) Benzimidazolderivater
ID22500A (id) Turunan sulfonamida
ID24430A (id) Turunan-turunan benzamidina
DE19810476B4 (de) Laryngomaske
ATA93198A (de) Fluoxetinpellets
DE59803185D1 (de) Baulaser
DE59802506D1 (de) Weichspülmittelzusammemsetzung
DE59804377D1 (de) Kryoventil
DE59804631D1 (de) Diketopyrrolopyrrolzusammensetzungen
FI972713A0 (fi) Bildskaerm
FI974316A0 (fi) Antennkonstruktion
DE59801498D1 (de) Dioxacycloalkan-8-one
DE59710388D1 (de) Mikropolarimeter
ATE236897T1 (de) 3-benzylpiperidine
ATA112597A (de) Snowboard - bindung
ID20897A (id) Susunan penutup-rapat
DE59805424D1 (de) Transversalmodenresonatorfilter
DE59805053D1 (de) Bogenflexodruckmaschine
ATA86797A (de) Verschleissschuh
ATA46498A (de) Kunststoffgleitbahn
DE59800820D1 (de) Stiellose kniegelenkendoprothese
BR9701194A (pt) Hidrociclo
FI973077A0 (fi) Haestsko
DE59804542D1 (de) Arylaminomethylencampherderivate
ATE421585T1 (de) Motlinhomologe